Post by AZAFAROS B.V.

AZAFAROS B.V. is sponsoring and attending the XLVII Spanish Neuropediatrics Meeting (Reunón Anual de la Sociedad Española de Neurología Pediátrica - SENEP), which starts today (14 May) in Málaga. We are looking forward to engaging with physicians at our booth (Stand #2), sharing information about our lead asset, #nizubaglustat, and our targeted diseases (#NPC, #GM1, and #GM2), and providing an update on our #Phase3 clinical study, #NAVIGATE. Come and talk with us! #RareDisease #DrugDevelopment, #Conferencing, #SENEP, #GM1, #GM2, #NPC